Company intelligence / Profile preview

Valderma

Ownership: Private
Development stage: Commercial

Overview

Valderma offers a broad portfolio of nutraceuticals, food supplements, probiotics, vitamins/minerals, and topical wellness/cosmetic products targeting various aspects of human health including circulation, digestion, pregnancy/lactation support, menopause/menstrual symptoms relief, prostate function, skin/hair/nail care. No clinical trial data is referenced; these are over-the-counter or supplement-type offerings rather than prescription pharmaceuticals.

Therapeutic areas: Men's HealthDermatologyGastroenterologyCardiovascularWomen's Health
Modalities: NutraceuticalsFood supplementsProbioticsVitamins and minerals
Industry: Food & Nutrition

Drug pipeline

5 assets

Alopex

Commercial

Indications: Hair loss

4 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Valderma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Valderma.

Explore the full profile